Skip to main content
. 2023 Apr 26;22:51. doi: 10.1186/s12904-023-01155-y

Table 2.

Prognostication accuracy in the full cohort and stratified across major disease groups. Full prognosis cohort includes individuals with a primary diagnosis classified as “cancer”, “dementia/frailty”, “heart disease”, “respiratory disease” and “other”. Shaded cells for the “Prediction” and “Survival” denote those for whom the prediction was accurate. Weighted Kappa denotes the agreement between prognostication outcome and survival, the higher the value the better the prognostic ability. Q1 First quartile, the value in the dataset that holds 25% of the values below it. Q3 Third Quartile, the value in the dataset that holds 25% of the values above it

Survival (n, % of row total) Median survival (Days) Interquartile range(Days) Weighted Kappa
Prognostic accuracy table—Full prognosis cohort (Overall 62% agreement between prediction and survival)
 Prediction Days Weeks Months Years Σ (% grand total) Q1 Q3 0.634
  Days 2,420 (74.2%) 412 (12.6%) 173 (5.3%) 255 (7.8%) 3,260 (3.3%) 4 2 13
  Weeks 4,415 (35.4%) 3,972 (31.9%) 2,364 (19.0%) 1,706 (13.7%) 12,457 (12.7%) 24 8 86
  Months 2,256 (8.3%) 5,976 (22.0%) 8,738 (32.2%) 10,153 (37.4%) 27,123 (27.6%) 146 41 535
  Years 585 (1.1%) 1,916 (3.5%) 6,926 (12.5%) 45,920 (83.0%) 55,347 (56.4%) 639 456 914
  Σ (% grand total) 9,676 (9.9%) 12,276 (12.5%) 18,201 (18.5%) 58,034 (59.1%) 98,187
Prognostic accuracy table—Patients with Cancer
 Prediction Days Weeks Months Years Σ (% grand total) Q1 Q3 0.725
  Days 1,049 (79.5%) 184 (13.9%) 60 (4.5%) 27 (2.0%) 1,320 (4.8%) 4 2 11
  Weeks 2,500 (37.5%) 2,496 (37.5%) 1,207 (18.1%) 459 (6.9%) 6,662 (24.1%) 21 9 56
  Months 1,236 (9.6%) 3,860 (29.8%) 4,919 (38.0%) 2,919 (22.6%) 12,934 (46.8%) 83 32 239
  Years 101 (1.5%) 510 (7.6%) 1,544 (23.0%) 4,564 (67.9%) 6,719 (24.3%) 578 200 730
Σ (% grand total) 4,886 (17.7%) 7,050 (25.5%) 7,730 (28.0%) 7,969 (28.8%) 27,635
Prognostic accuracy table—Patients with Dementia/Frailty
 Prediction Days Weeks Months Years Σ (% grand total) Q1 Q3 0.749
  Days 550 (74.9%) 67 (9.1%) 40 (5.4%) 77 (10.5%) 734 (3.6%) 4 2 13
  Weeks 866 (38.4%) 449 (19.9%) 402 (17.8%) 541 (24.0%) 2,258 (11.0%) 28 7 261
  Months 463 (8.4%) 690 (12.5%) 1,374 (24.9%) 2,987 (54.1%) 5,514 (26.9%) 395 80 670
  Years 206 (1.7%) 502 (4.2%) 1,856 (15.5%) 9,405 (78.6%) 11,969 (58.5%) 609 395 761
Σ (% grand total) 2,085 (10.2%) 1,708 (8.3%) 3,672 (17.9%) 13,000 (63.5%) 20,475
Prognostic accuracy table—Patients with Heart Disease
 Prediction Days Weeks Months Years Σ (% grand total) Q1 Q3 0.666
  Days 247 (69.2%) 48 (13.4%) 19 (5.3%) 43 (12.0%) 357 (2.4%) 4 1 20
  Weeks 408 (36.2%) 267 (23.7%) 231 (20.5%) 220 (19.5%) 1,126 (7.5%) 30 7 174
  Months 250 (9.5%) 370 (14.1%) 709 (26.9%) 1302 (49.5%) 2,631 (17.6%) 308 61 639
  Years 114 (1.1%) 291 (2.7%) 1096 (10.1%) 9350 (86.2%) 10,851 (72.5%) 639 517 1064
Σ (% grand total) 1,019 (6.8%) 976 (6.5%) 2,056 (13.7%) 10,914 (72.9%) 14,965
Prognostic accuracy table—Patients with Respiratory disease
 Prediction Days Weeks Months Years Σ (% grand total)) Q1 Q3 0.660
  Days 122 (63.5%) 23 (12.0%) 12 (6.3%) 35 (18.2%) 192 (2.4%) 5 1 34
  Weeks 201 (35.1%) 132 (23.1%) 112 (19.6%) 127 (22.2%) 572 (7.2%) 34 8 234
  Months 139 (8.2%) 293 (17.4%) 526 (31.2%) 728 (43.2%) 1,686 (21.3%) 220 54 609
  Years 44 (0.8%) 138 (2.5%) 630 (11.5%) 4,664 (85.2%) 5,476 (69.1%) 639 517 806
Σ (% grand total) 506 (6.4%) 586 (7.4%) 1,280 (16.1%) 5,554 (70.1%) 7,926
OSZAR »